Anandamide was the first endogenous ligand of cannabinoid receptors to be d
iscovered in 1992. Yet, this compound also efficiently activates receptors
specific for capsaicin, known as vanilloid type 1 receptors (VR1). Whether
anandamide is a physiological VR1 ligand is controversial. However, very re
cent reports demonstrate that activation of VR1 by anandamide can be signif
icantly enhanced by various regulatory factors, suggesting that this compou
nd might act as an 'endovanilloid' under certain conditions.